These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15214881

  • 1. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR, Lütticken R, Al-Lahham A.
    Clin Microbiol Infect; 2004 Jul; 10(7):659-62. PubMed ID: 15214881
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.
    Clin Infect Dis; 2003 Feb 01; 36(3):380-3. PubMed ID: 12539083
    [Abstract] [Full Text] [Related]

  • 3. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May 01; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 4. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.
    J Antimicrob Chemother; 2007 Jan 01; 59(1):28-34. PubMed ID: 17065188
    [Abstract] [Full Text] [Related]

  • 5. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA.
    J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373
    [Abstract] [Full Text] [Related]

  • 6. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.
    J Antimicrob Chemother; 2011 Mar 15; 66(3):494-8. PubMed ID: 21172783
    [Abstract] [Full Text] [Related]

  • 7. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
    Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.
    J Antimicrob Chemother; 2012 Nov 15; 67(11):2602-5. PubMed ID: 22815354
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 9. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
    Alonso R, Mateo E, Ezpeleta G, Cisterna R.
    Int J Antimicrob Agents; 2007 Aug 15; 30(2):183-5. PubMed ID: 17543504
    [Abstract] [Full Text] [Related]

  • 10. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.
    Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, Klugman KP.
    Antimicrob Agents Chemother; 2006 Mar 15; 50(3):943-8. PubMed ID: 16495255
    [Abstract] [Full Text] [Related]

  • 11. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct 15; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 12. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
    Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P.
    Clin Microbiol Infect; 2005 Sep 15; 11(9):759-61. PubMed ID: 16104992
    [Abstract] [Full Text] [Related]

  • 13. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ, Cho JK, Kim KS, Tak RB, Kim AR, Kim JW, Im SK, Kim BH.
    J Microbiol; 2005 Oct 15; 43(5):391-7. PubMed ID: 16273029
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
    Powis J, McGeer A, Duncan C, Goren R, de Azavedo JC, Bast DJ, Pong-Porter S, Mazzulli T, Green K, Willey B, Low DE.
    Antimicrob Agents Chemother; 2005 May 15; 49(5):2130-2. PubMed ID: 15855546
    [Abstract] [Full Text] [Related]

  • 15. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK, Lee YS, Park YK, Kim BS.
    Int J Antimicrob Agents; 2005 Apr 15; 25(4):290-5. PubMed ID: 15784307
    [Abstract] [Full Text] [Related]

  • 16. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2005 Oct 15; 56(4):769-72. PubMed ID: 16126779
    [Abstract] [Full Text] [Related]

  • 17. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y, Pei X, Liu X.
    Wei Sheng Yan Jiu; 2004 Sep 15; 33(5):591-4. PubMed ID: 15612489
    [Abstract] [Full Text] [Related]

  • 18. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S, Yasuda M, Ito S, Takahashi Y, Ishihara S, Deguchi T, Maeda S, Kubota Y, Tamaki M, Fukushi H.
    J Infect Chemother; 2004 Oct 15; 10(5):262-7. PubMed ID: 16163459
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
    Misiurina OIu, Shipitsina EV, Finashutina IuP, Lazarev VN, Akopian TA, Savicheva AM, Govorun VM.
    Mol Gen Mikrobiol Virusol; 2004 Oct 15; (3):3-7. PubMed ID: 15354934
    [Abstract] [Full Text] [Related]

  • 20. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman MA, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jun 15; 55(2):119-27. PubMed ID: 16530373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.